Results 61 to 70 of about 23,087 (229)

Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study

open access: yesJournal of Pharmaceutical Health Care and Sciences, 2023
Background Long-term care issues, specifically metabolic bone disorders, are a concern for people living with human immunodeficiency virus (PLWH) who undergo life-long antiretroviral therapy (ART).
Yusuke Kunimoto   +7 more
doaj   +1 more source

Denosumab Use in Chronic Kidney Disease Associated Osteoporosis: A Narrative Review

open access: yes, 2023
Abduelmula R Abduelkarem,1,2 Adnane Guella,3 Amar M Hamrouni,4 Mohammed M Hassanein,1 Ahmed Nasr,5 Owais Rana6 1Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; 2Research
Hassanein MM   +5 more
core  

Hypophosphataemia in adults: approach to diagnosis and management

open access: yesInternal Medicine Journal, EarlyView.
Abstract Hypophosphataemia is a common electrolyte disorder which can have clinically significant consequences for bone, muscle, neurological and haematological function. Its causes range from transient transcellular shifts in hospitalised patients to chronic renal phosphate‐wasting disorders mediated by fibroblast growth factor 23 (FGF23).
Kajanan Parameshwaran   +2 more
wiley   +1 more source

Denosumab [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2011
Eline A, Dubois   +2 more
openaire   +3 more sources

Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab

open access: yesCase Reports in Medicine, 2015
Giant cell tumor (GCT) of bone is a generally benign, but often locally aggressive, neoplasm of bone, with a propensity for recurrence. Sarcomatous transformation is rare and typically occurs with a history of recurrences and radiation treatment ...
Cory Julian Broehm   +3 more
doaj   +1 more source

Bisphosphonate- and disumab-related gingival disorders: case analysis from the U.S. Food and Drug Administration Adverse Event Reporting System

open access: yesFrontiers in Endocrinology
Prior research has indicated that bisphosphonates (BPs) can improve periodontal disease because of their anti-osteoporosis properties. In vitro studies have shown that BPs induce cytotoxicity, inhibit wound healing, and thus affect periodontal disease ...
Lei Wang   +3 more
doaj   +1 more source

Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer

open access: yes, 2019
Denosumab is a fully human MAB that acts as a potent anti-resorptive by inhibiting activation of osteoclasts by inhibiting the receptor activator of nuclear factor-kappa B (RANK) ligand.
E George (9869552)   +2 more
core  

Modified Osseodensification Bur (Sun Bur) for Transcrestal Sinus Floor Elevation With 2–6 mm Residual Bone Height: A Retrospective Cohort Study

open access: yesJournal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective To evaluate the clinical efficacy of a modified osseodensification (OD) bur for transcrestal sinus floor elevation (tSFE) and to compare clinical outcomes between patients with residual bone height (RBH) of 2–< 4 mm (Group A) and 4–6 mm (Group B).
Mingxu Sun   +4 more
wiley   +1 more source

Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk

open access: yes, 2022
In this retrospective study, the effectiveness of short-term teriparatide with denosumab in reducing fragility fracture risk was determined in comparison with denosumab monotherapy.
신재원, 김학선
core   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Sabine Elisabeth Groeger   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy